Review



bnt162b2 vaccine booster dose  (Moderna)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Moderna bnt162b2 vaccine booster dose
    Summary on the Efficacy of Different COVID 19 Vaccines Against Omicron SARS-CoV-2 Variant
    Bnt162b2 Vaccine Booster Dose, supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bnt162b2 vaccine booster dose/product/Moderna
    Average 90 stars, based on 1 article reviews
    bnt162b2 vaccine booster dose - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Mutational Pattern, Impacts and Potential Preventive Strategies of Omicron SARS-CoV-2 Variant Infection"

    Article Title: Mutational Pattern, Impacts and Potential Preventive Strategies of Omicron SARS-CoV-2 Variant Infection

    Journal: Infection and Drug Resistance

    doi: 10.2147/IDR.S360103

    Summary on the Efficacy of Different COVID 19 Vaccines Against Omicron SARS-CoV-2 Variant
    Figure Legend Snippet: Summary on the Efficacy of Different COVID 19 Vaccines Against Omicron SARS-CoV-2 Variant

    Techniques Used: Neutralization, Variant Assay, Activity Assay, Infection, Binding Assay



    Similar Products

    covid-19 booster dose-vaccine pfizer-biontech (bnt162b2  (BioNTech)
    90
    BioNTech covid-19 booster dose-vaccine pfizer-biontech (bnt162b2
    Total number of <t>COVID‐19</t> vaccine side‐effects reported among the participants associated with COVID-19 Booster dose-vaccine of Pfizer-BioNTech (BNT162b2) among respondents.
    Covid 19 Booster Dose Vaccine Pfizer Biontech (Bnt162b2, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/covid-19 booster dose-vaccine pfizer-biontech (bnt162b2/product/BioNTech
    Average 90 stars, based on 1 article reviews
    covid-19 booster dose-vaccine pfizer-biontech (bnt162b2 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    booster dose pfizer-biontech/bnt162b2 vaccine  (BioNTech)
    90
    BioNTech booster dose pfizer-biontech/bnt162b2 vaccine
    Total number of <t>COVID‐19</t> vaccine side‐effects reported among the participants associated with COVID-19 Booster dose-vaccine of Pfizer-BioNTech (BNT162b2) among respondents.
    Booster Dose Pfizer Biontech/Bnt162b2 Vaccine, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/booster dose pfizer-biontech/bnt162b2 vaccine/product/BioNTech
    Average 90 stars, based on 1 article reviews
    booster dose pfizer-biontech/bnt162b2 vaccine - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    booster bnt162b2 mrna vaccine dose  (BioNTech)
    90
    BioNTech booster bnt162b2 mrna vaccine dose
    Characteristics of participants in study of self-reported and physiologic reactions to third <t> BNT162b2 mRNA </t> coronavirus disease (booster) vaccine dose*
    Booster Bnt162b2 Mrna Vaccine Dose, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/booster bnt162b2 mrna vaccine dose/product/BioNTech
    Average 90 stars, based on 1 article reviews
    booster bnt162b2 mrna vaccine dose - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    covid-19 bnt162b2 vaccine booster dose  (BioNTech)
    90
    BioNTech covid-19 bnt162b2 vaccine booster dose
    Characteristics of participants in study of self-reported and physiologic reactions to third <t> BNT162b2 mRNA </t> coronavirus disease (booster) vaccine dose*
    Covid 19 Bnt162b2 Vaccine Booster Dose, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/covid-19 bnt162b2 vaccine booster dose/product/BioNTech
    Average 90 stars, based on 1 article reviews
    covid-19 bnt162b2 vaccine booster dose - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    bnt162b2 vaccine booster dose  (Moderna)
    90
    Moderna bnt162b2 vaccine booster dose
    Summary on the Efficacy of Different COVID 19 Vaccines Against Omicron SARS-CoV-2 Variant
    Bnt162b2 Vaccine Booster Dose, supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bnt162b2 vaccine booster dose/product/Moderna
    Average 90 stars, based on 1 article reviews
    bnt162b2 vaccine booster dose - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Total number of COVID‐19 vaccine side‐effects reported among the participants associated with COVID-19 Booster dose-vaccine of Pfizer-BioNTech (BNT162b2) among respondents.

    Journal: Infection Prevention in Practice

    Article Title: Prevalence of side‐effects associated with the booster dose of Pfizer-BioNTech (BNT162b2) of COVID-19 Vaccine among vaccinated adults in the Eastern province of Saudi Arabia

    doi: 10.1016/j.infpip.2022.100251

    Figure Lengend Snippet: Total number of COVID‐19 vaccine side‐effects reported among the participants associated with COVID-19 Booster dose-vaccine of Pfizer-BioNTech (BNT162b2) among respondents.

    Article Snippet: Total number of COVID‐19 vaccine side‐effects reported among the participants associated with COVID-19 Booster dose-vaccine of Pfizer-BioNTech (BNT162b2) among respondents.

    Techniques:

    Frequency and types of side‐effects associated with COVID-19 Vaccines among respondents.

    Journal: Infection Prevention in Practice

    Article Title: Prevalence of side‐effects associated with the booster dose of Pfizer-BioNTech (BNT162b2) of COVID-19 Vaccine among vaccinated adults in the Eastern province of Saudi Arabia

    doi: 10.1016/j.infpip.2022.100251

    Figure Lengend Snippet: Frequency and types of side‐effects associated with COVID-19 Vaccines among respondents.

    Article Snippet: Total number of COVID‐19 vaccine side‐effects reported among the participants associated with COVID-19 Booster dose-vaccine of Pfizer-BioNTech (BNT162b2) among respondents.

    Techniques:

    Characteristics of participants in study of self-reported and physiologic reactions to third BNT162b2 mRNA coronavirus disease (booster) vaccine dose*

    Journal: Emerging Infectious Diseases

    Article Title: Self-Reported and Physiologic Reactions to Third BNT162b2 mRNA COVID-19 (Booster) Vaccine Dose

    doi: 10.3201/eid2807.212330

    Figure Lengend Snippet: Characteristics of participants in study of self-reported and physiologic reactions to third BNT162b2 mRNA coronavirus disease (booster) vaccine dose*

    Article Snippet: We conducted a prospective observational study to evaluate short-term self-reported and physiologic reactions to the booster BNT162b2 mRNA (Pfizer-BioNTech, https://www.pfizer.com ) vaccine dose.

    Techniques:

    Reactions reported by participants through a mobile application for self-reported and physiologic reactions to BNT162b2 (Pfizer, https://www.pfizer.com ) mRNA coronavirus disease vaccine doses. Error bars indicate 90% CIs.

    Journal: Emerging Infectious Diseases

    Article Title: Self-Reported and Physiologic Reactions to Third BNT162b2 mRNA COVID-19 (Booster) Vaccine Dose

    doi: 10.3201/eid2807.212330

    Figure Lengend Snippet: Reactions reported by participants through a mobile application for self-reported and physiologic reactions to BNT162b2 (Pfizer, https://www.pfizer.com ) mRNA coronavirus disease vaccine doses. Error bars indicate 90% CIs.

    Article Snippet: We conducted a prospective observational study to evaluate short-term self-reported and physiologic reactions to the booster BNT162b2 mRNA (Pfizer-BioNTech, https://www.pfizer.com ) vaccine dose.

    Techniques:

    Changes in subjective well-being indicators reported by participants through a mobile application for self-reported and physiologic reactions to BNT162b2 (Pfizer, https://www.pfizer.com ) mRNA coronavirus disease vaccine doses. Mean difference compared with baseline levels are shown for the well-being indicators of mood level (A), stress level (B), sport duration (C), and sleep quality (D). Mood level, stress level, and sleep quality were reported on a 1–5 Likert scale. Sport duration was measured in minutes. Error bars indicate 90% CIs. Horizontal dashed lines indicate no change compared with baseline levels.

    Journal: Emerging Infectious Diseases

    Article Title: Self-Reported and Physiologic Reactions to Third BNT162b2 mRNA COVID-19 (Booster) Vaccine Dose

    doi: 10.3201/eid2807.212330

    Figure Lengend Snippet: Changes in subjective well-being indicators reported by participants through a mobile application for self-reported and physiologic reactions to BNT162b2 (Pfizer, https://www.pfizer.com ) mRNA coronavirus disease vaccine doses. Mean difference compared with baseline levels are shown for the well-being indicators of mood level (A), stress level (B), sport duration (C), and sleep quality (D). Mood level, stress level, and sleep quality were reported on a 1–5 Likert scale. Sport duration was measured in minutes. Error bars indicate 90% CIs. Horizontal dashed lines indicate no change compared with baseline levels.

    Article Snippet: We conducted a prospective observational study to evaluate short-term self-reported and physiologic reactions to the booster BNT162b2 mRNA (Pfizer-BioNTech, https://www.pfizer.com ) vaccine dose.

    Techniques:

    Changes in objective physiologic indicators measured through smartwatch for self-reported and physiologic reactions to BNT162b2 (Pfizer, https://www.pfizer.com ) mRNA coronavirus disease vaccine doses. Mean difference are shown for smartwatch-recorded heart rate (A‒C), HRV-based stress (D‒F), and SpO 2 (G‒I) after the first, second, and third dose compared with their baseline levels. Mean values are indicated by solid lines; 90% CIs are indicated as shaded regions. Horizontal dashed line indicates no change compared with baseline levels, and vertical lines indicate 24-hour periods. HRV, heart-related variability; SpO 2 , blood oxygen saturation level.

    Journal: Emerging Infectious Diseases

    Article Title: Self-Reported and Physiologic Reactions to Third BNT162b2 mRNA COVID-19 (Booster) Vaccine Dose

    doi: 10.3201/eid2807.212330

    Figure Lengend Snippet: Changes in objective physiologic indicators measured through smartwatch for self-reported and physiologic reactions to BNT162b2 (Pfizer, https://www.pfizer.com ) mRNA coronavirus disease vaccine doses. Mean difference are shown for smartwatch-recorded heart rate (A‒C), HRV-based stress (D‒F), and SpO 2 (G‒I) after the first, second, and third dose compared with their baseline levels. Mean values are indicated by solid lines; 90% CIs are indicated as shaded regions. Horizontal dashed line indicates no change compared with baseline levels, and vertical lines indicate 24-hour periods. HRV, heart-related variability; SpO 2 , blood oxygen saturation level.

    Article Snippet: We conducted a prospective observational study to evaluate short-term self-reported and physiologic reactions to the booster BNT162b2 mRNA (Pfizer-BioNTech, https://www.pfizer.com ) vaccine dose.

    Techniques:

    Self-reported and objective reactions following the third vaccine dose, stratified by age, sex, and underlying medical condition for self-reported and physiologic reactions to third BNT162b2 (Pfizer, https://www.pfizer.com ) mRNA coronavirus disease vaccine doses. Reactions reported by participants through the mobile application (A, C, E) and objective heart rate and heart rate variability measured through a smartwatch (B, D, F) are shown, stratified by age (A, B), sex (C, D), and underlying medical condition (E, F). Bars indicate percentage of participants with a reported or recorded reaction; error bars indicate 90% CIs.

    Journal: Emerging Infectious Diseases

    Article Title: Self-Reported and Physiologic Reactions to Third BNT162b2 mRNA COVID-19 (Booster) Vaccine Dose

    doi: 10.3201/eid2807.212330

    Figure Lengend Snippet: Self-reported and objective reactions following the third vaccine dose, stratified by age, sex, and underlying medical condition for self-reported and physiologic reactions to third BNT162b2 (Pfizer, https://www.pfizer.com ) mRNA coronavirus disease vaccine doses. Reactions reported by participants through the mobile application (A, C, E) and objective heart rate and heart rate variability measured through a smartwatch (B, D, F) are shown, stratified by age (A, B), sex (C, D), and underlying medical condition (E, F). Bars indicate percentage of participants with a reported or recorded reaction; error bars indicate 90% CIs.

    Article Snippet: We conducted a prospective observational study to evaluate short-term self-reported and physiologic reactions to the booster BNT162b2 mRNA (Pfizer-BioNTech, https://www.pfizer.com ) vaccine dose.

    Techniques:

    Summary on the Efficacy of Different COVID 19 Vaccines Against Omicron SARS-CoV-2 Variant

    Journal: Infection and Drug Resistance

    Article Title: Mutational Pattern, Impacts and Potential Preventive Strategies of Omicron SARS-CoV-2 Variant Infection

    doi: 10.2147/IDR.S360103

    Figure Lengend Snippet: Summary on the Efficacy of Different COVID 19 Vaccines Against Omicron SARS-CoV-2 Variant

    Article Snippet: Schmidt et al, 2022. , Ad26 and mRNA (BNT162b2 or Moderna) vaccine , Neutralizing antibody titers against Omicron were significantly low in Ad26 vaccine or two dose mRNA vaccine recipients. Sera from recipients of two mRNA vaccine doses were reported to be 30–180-fold less potent against Omicron than Wuhan-hu-1. The vaccine boosters significantly ameliorate SARS CoV-2 neutralization titers. Administering an extra mRNA (BNT162b2 or Moderna) vaccine booster dose to previously infected or two-mRNA dose vaccinated individuals increases neutralizing activity against Omicron by 38–154-fold..

    Techniques: Neutralization, Variant Assay, Activity Assay, Infection, Binding Assay